Name:
Institution:
Type:
PI
Research Objective
Locally delivered formulation of RSpo1 protein as an activator of Lgr5+ epithelial stem cells in chemotherapy- or radiation therapy-induced oral mucositis
Impact
Oral mucositis
Major Proposed Activities
The proposed research will provide a new therapy for the prevention and treatment of oral mucositis - a common complication of chemotherapy and radiation therapy for cancer patients in California, the US, and globally. If successful, the product development program will also enable growth of the company which will bring more jobs and opportunities for California citizens, as the company is based here.